Intuitive Surgical, Inc. (ISRG)

From the record

Intuitive Surgical, Inc.'s filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Intuitive Surgical, Inc.'s 10 filed years say what it did: revenue went from $2.7 billion in fiscal 2016 to $10 billion in fiscal 2025, up 15.7% a year; it rose in 8 of 9 years; the deepest fall was 3% from fiscal 2019 to fiscal 2020; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Intuitive Surgical, Inc.'s diluted share count grew about 0.1% a year, and dividends and buybacks returned about 37% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 76 sales (76 under scheduled 10b5-1 plans) and 0 purchases of their own stock on the open market in the year to 2026-11-12 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Intuitive Surgical, Inc. earned about 16 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 32 cents per dollar of everything the company owns. Leverage: it owed about 13 cents per dollar of assets, and net share issuance: its share count grew 0.2% over the year (the filed statements).

From the record

Intuitive Surgical, Inc.'s standing among 26 graded names in its industry family: revenue of $10 billion in fiscal 2025 ranks in the top 2% by size; a net margin of 28.4% ranks in the top 2%; revenue growth of 17.4% a year over the last 3 filed years ranks in the top 24% (its annual reports).

From the record

Intuitive Surgical, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Rosa, David J. (Chief Executive Officer (CEO), as filed), filing under that title since 2025-07-11, 1.3 years (bottom 9% of its family); the 20 officers and directors filing in the last fifteen months have been on the record a median of 6.1 years (top 47%); 9 officer or director changes were reported on Form 8-K since 2023-11-13, against the 20 people in charge now (top 32%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Intuitive Surgical, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $3.4 billion against no long-term debt tagged leaves 16.5% of its assets as net cash, top 46% of its family; cash from operations less capital spending is 24.7% of revenue (top 2%); a gross margin of 66% (top 34%); research spending of 13% of revenue (top 46%) (its annual report).

From the record

Intuitive Surgical, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 17.4% a year over the last three filed years against 15.7% over all 10, speeding up (top 46% of its family); the newest year grew 20.5% (top 14%); research spending grew 14.3% a year (top 31%); capital spending grew 0.5% a year (bottom 40%) (its annual reports). Intuitive Surgical, Inc. reported 3 product lines in fiscal 2025: Instruments and Accessories at $6.0 billion (60%), Systems at $2.5 billion (25%), Service at $1.6 billion (16%); 3 of 3 grew against the year before (its annual report).

From the record

Intuitive Surgical, Inc.'s newest year against its own record: revenue of $10 billion in fiscal 2025 came in 4% above the $9.7 billion its prior three years' pace pointed to (top 35% of its family); net income of $2.9 billion against a prior three-year average of $1.8 billion (top 24%); a net margin of 28.4% against 24.8% before (top 41%) (its annual reports).